poisar

Stocks · News reference

ImmunityBio Announces Survey Findings on Military Service Members and Veterans with Non-Muscle Invasive Bladder Cancer

Fiscal.ai

ImmunityBio released results from a national survey conducted by The Harris Poll, highlighting diagnosis trends and care barriers for military personnel with NMIBC.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. BenzingaVandana Singh

    ImmunityBio Reports Wider Quarterly Loss

    ImmunityBio stock falls as Q3 revenue misses estimates, despite positive ANKTIVA bladder cancer trial results and Israeli approval.